# Jasper Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2020

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 10-K/A
- Filed: 2021-07-19
- Accepted by EDGAR: Jul 16, 2021, 19:00 ET
- Period: 2020-12-31
- Accession: 0001213900-21-037315
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021037315/f10k2020a2_amplitude.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021037315/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021037315/f10k2020a2_amplitude.htm

Filed Jul 19, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-037315. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
